These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 7975254)

  • 1. Biochemical characterization of Epstein-Barr virus nuclear antigen 3A and 3C proteins.
    Sample C; Parker B
    Virology; 1994 Dec; 205(2):534-9. PubMed ID: 7975254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-barr virus nuclear antigen 3C activates the latent membrane protein 1 promoter in the presence of Epstein-Barr virus nuclear antigen 2 through sequences encompassing an spi-1/Spi-B binding site.
    Zhao B; Sample CE
    J Virol; 2000 Jun; 74(11):5151-60. PubMed ID: 10799590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional regulatory properties of Epstein-Barr virus nuclear antigen 3C are conserved in simian lymphocryptoviruses.
    Zhao B; Dalbiès-Tran R; Jiang H; Ruf IK; Sample JT; Wang F; Sample CE
    J Virol; 2003 May; 77(10):5639-48. PubMed ID: 12719556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural, functional, and genetic comparisons of Epstein-Barr virus nuclear antigen 3A, 3B, and 3C homologues encoded by the rhesus lymphocryptovirus.
    Jiang H; Cho YG; Wang F
    J Virol; 2000 Jul; 74(13):5921-32. PubMed ID: 10846073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation.
    Tomkinson B; Robertson E; Kieff E
    J Virol; 1993 Apr; 67(4):2014-25. PubMed ID: 8445720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EBNA-3B- and EBNA-3C-regulated cellular genes in Epstein-Barr virus-immortalized lymphoblastoid cell lines.
    Chen A; Zhao B; Kieff E; Aster JC; Wang F
    J Virol; 2006 Oct; 80(20):10139-50. PubMed ID: 17005691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus EBNA-3C is targeted to and regulates expression from the bidirectional LMP-1/2B promoter.
    Jiménez-Ramírez C; Brooks AJ; Forshell LP; Yakimchuk K; Zhao B; Fulgham TZ; Sample CE
    J Virol; 2006 Nov; 80(22):11200-8. PubMed ID: 16956945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precipitation of the Epstein-Barr virus protein EBNA 2 by an EBNA 3c-specific monoclonal antibody.
    Maunders MJ; Petti L; Rowe M
    J Gen Virol; 1994 Apr; 75 ( Pt 4)():769-78. PubMed ID: 7512118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein J kappa.
    Robertson ES; Grossman S; Johannsen E; Miller C; Lin J; Tomkinson B; Kieff E
    J Virol; 1995 May; 69(5):3108-16. PubMed ID: 7707539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA-binding studies of the Epstein-Barr virus nuclear antigen 2 (EBNA-2): evidence for complex formation by latent membrane protein gene promoter-binding proteins in EBNA-2-positive cell lines.
    Sauder C; Haiss P; Grässer FA; Zimber-Strobl U; Mueller-Lantzsch N
    J Gen Virol; 1994 Nov; 75 ( Pt 11)():3067-79. PubMed ID: 7964616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinction between Epstein-Barr virus type A (EBNA 2A) and type B (EBNA 2B) isolates extends to the EBNA 3 family of nuclear proteins.
    Rowe M; Young LS; Cadwallader K; Petti L; Kieff E; Rickinson AB
    J Virol; 1989 Mar; 63(3):1031-9. PubMed ID: 2536817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus nuclear antigen 3C is a transcriptional regulator.
    Marshall D; Sample C
    J Virol; 1995 Jun; 69(6):3624-30. PubMed ID: 7745710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus nuclear antigen 3C putative repression domain mediates coactivation of the LMP1 promoter with EBNA-2.
    Lin J; Johannsen E; Robertson E; Kieff E
    J Virol; 2002 Jan; 76(1):232-42. PubMed ID: 11739688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biophysical and mutational analysis of the putative bZIP domain of Epstein-Barr virus EBNA 3C.
    West MJ; Webb HM; Sinclair AJ; Woolfson DN
    J Virol; 2004 Sep; 78(17):9431-45. PubMed ID: 15308737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells.
    Allday MJ; Crawford DH; Thomas JA
    J Gen Virol; 1993 Mar; 74 ( Pt 3)():361-9. PubMed ID: 8383171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia viruses.
    Murray RJ; Kurilla MG; Griffin HM; Brooks JM; Mackett M; Arrand JR; Rowe M; Burrows SR; Moss DJ; Kieff E
    Proc Natl Acad Sci U S A; 1990 Apr; 87(8):2906-10. PubMed ID: 2158098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Epstein-Barr virus determined nuclear antigens EBNA-3A, -3B, and -3C repress EBNA-2-mediated transactivation of the viral terminal protein 1 gene promoter.
    Le Roux A; Kerdiles B; Walls D; Dedieu JF; Perricaudet M
    Virology; 1994 Dec; 205(2):596-602. PubMed ID: 7975264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation.
    Cohen JI; Wang F; Mannick J; Kieff E
    Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9558-62. PubMed ID: 2556717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised.
    Hill AB; Lee SP; Haurum JS; Murray N; Yao QY; Rowe M; Signoret N; Rickinson AB; McMichael AJ
    J Exp Med; 1995 Jun; 181(6):2221-8. PubMed ID: 7539044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1.
    Wrightham MN; Stewart JP; Janjua NJ; Pepper SD; Sample C; Rooney CM; Arrand JR
    Virology; 1995 Apr; 208(2):521-30. PubMed ID: 7538250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.